TGFB1 genetic polymorphisms and coronary heart disease risk: a meta-analysis

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Lu, Yingchang ^a,b   Boer, Jolanda M A ^b   Barsova, Roza M ^c   Favorova, Olga ^c   Goel, Anuj ^d   Müller, Michael ^a   Feskens, Edith J M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CORONARY RISK; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MEDLINE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84861172167     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-39     Document Type: Article

References (64)

1. Pardali E, Goumans MJ, ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 2010, 20(9):556-567. 10.1016/j.tcb.2010.06.006, 20656490.
2. Khan R, Agrotis A, Bobik A. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res 2007, 74(2):223-234. 10.1016/j.cardiores.2007.02.012, 17349984.
3. Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, Dichek DA. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci U S A 1998, 95(12):6983-6988. 10.1073/pnas.95.12.6983, 22710, 9618525.
4. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 2000, 97(7):3479-3484. 16265, 10725360.
5. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 1991, 88(3):904-910. 10.1172/JCI115393, 295478, 1832175.
6. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, Jaffe M, Dichek HL, Pennington CJ, Edwards DR, Nieves-Cintron M, et al. TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2009, 29(9):1251-1257. 10.1161/ATVBAHA.109.186593, 2740721, 19325140.
7. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 1992, 90(4):1582-1592. 10.1172/JCI116027, 443206, 1328302.
8. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A 1993, 90(22):10759-10763. 10.1073/pnas.90.22.10759, 47857, 8248168.
9. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995, 1(1):74-79. 10.1038/nm0195-74, 7584958.
10. Wang XL, Sim AS, Wilcken DE. A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease. Clin Sci (Lond) 1998, 95(6):745-746.
11. Najar RA, Ghaderian SM, Panah AS. Association of Transforming Growth Factor-beta1 Gene Polymorphisms With Genetic Susceptibility to Acute Myocardial Infarction. Am J Med Sci 2011, 342(5):365-370. 10.1097/MAJ.0b013e318215908a, 21685787.
12. McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, Bush HL. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J Clin Invest 1995, 96(6)):2667-2675. 185973, 8675633.
13. Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, Carlson OD, Griswold BF, Fu Q, De Backer J, et al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation 2009, 120(6):526-532. 10.1161/CIRCULATIONAHA.108.841981, 2779568, 19635970.
14. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 1998, 95(6):659-667.
15. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998, 13(10):1569-1576.
16. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996, 28(5)):881-887.
17. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999, 8(1):93-97. 10.1093/hmg/8.1.93, 9887336.
18. Shah R, Rahaman B, Hurley CK, Posch PE. Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 2006, 119(1-2):61-74.
19. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003, 63(10):2610-2615.
20. Koch W, Hoppmann P, Mueller JC, Schomig A, Kastrati A. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol 2006, 26(5):1114-1119. 10.1161/01.ATV.0000217747.66517.11, 16543493.
21. Sie MP, Uitterlinden AG, Bos MJ, Arp PP, Breteler MM, Koudstaal PJ, Pols HA, Hofman A, van Duijn CM, Witteman JC. TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. Stroke 2006, 37(11):2667-2671. 10.1161/01.STR.0000244779.30070.1a, 17023672.
22. Crobu F, Palumbo L, Franco E, Bergerone S, Carturan S, Guarrera S, Frea S, Trevi G, Piazza A, Matullo G. Role of TGF-beta1 haplotypes in the occurrence of myocardial infarction in young Italian patients. BMC Med Genet 2008, 9:13. 2270803, 18312614.
23. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29-C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000, 101(24):2783-2787. 10.1161/01.CIR.101.24.2783, 10859282.
24. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011, 43(4):333-338. 10.1038/ng.784, 3119261, 21378990.
25. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011, 43(4)):339-344.
26. Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends in genetics: TIG 2008, 24(10):489-497. 10.1016/j.tig.2008.07.004, 18778868.
27. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, Hall I, Kaufman J, Leung TF, et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162(3):201-211. 10.1093/aje/kwi184, 15987731.
28. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010, 11(7):499-511. 10.1038/nrg2796, 20517342.
29. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56(2):455-463. 10.1111/j.0006-341X.2000.00455.x, 10877304.
30. Viechtbauer W. Conducting meta-analyses in R with the metafor package. Journal of Statistical Software 2010, 36(3):1-48.
31. Wang Y, Luk AO, Ma RC, So WY, Tam CH, Ng MC, Yang X, Baum L, Lam V, Tong PC, et al. Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes-an 8-year prospective cohort analysis of 1297 patients. Diabet Med 2010, 27(4):376-383. 10.1111/j.1464-5491.2010.02980.x, 20536507.
32. Rao M, Guo D, Jaber BL, Tighiouart H, Pereira BJ, Balakrishnan VS. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int 2004, 66(1):419-427. 10.1111/j.1523-1755.2004.00748.x, 15200451.
33. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, Cokkinos DV. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 2008, 19(8):575-582. 10.1097/MCA.0b013e32831286e8, 19005292.
34. Oda K, Tanaka N, Arai T, Araki J, Song Y, Zhang L, Kuchiba A, Hosoi T, Shirasawa T, Muramatsu M, et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 2007, 16(6):592-599.
35. Wang Y, Fu W, Xie F, Chu X, Wang H, Shen M, Sun W, Lei R, Yang L, Wu H, et al. Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population. J Hum Genet 2010, 55(8):490-494. 10.1038/jhg.2010.53, 20485444.
36. Sudomoina MA, Sukhinina TS, Barsova RM, Favorov AV, Shakhnovich RM, Titov BV, Matveeva NA, Rybalkin IN, Vlasik TN, Ochs MF, et al. Complex analsis of association of inflammation genes with myocardial infarction. Mol Biol (Mosk) 2010, 44(3):463-471.
37. Drenos F, Talmud PJ, Casas JP, Smeeth L, Palmen J, Humphries SE, Hingorani AD. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet 2009, 18(12):2305-2316. 10.1093/hmg/ddp159, 2685759, 19336475.
38. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, Tararak E, Condron M, Kostolias G. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions, Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 1999, 99(22):2883-2891. 10.1161/01.CIR.99.22.2883, 10359732.
39. Piao M, Tokunaga O. Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. J Atheroscler Thromb 2006, 13(2):82-89. 10.5551/jat.13.82, 16733295.
40. Panutsopulos D, Papalambros E, Sigala F, Zafiropoulos A, Arvanitis DL, Spandidos DA. Protein and mRNA expression levels of VEGF-A and TGF-beta1 in different types of human coronary atherosclerotic lesions. Int J Mol Med 2005, 15(4):603-610.
41. O'Brien ER, Bennett KL, Garvin MR, Zderic TW, Hinohara T, Simpson JB, Kimura T, Nobuyoshi M, Mizgala H, Purchio A, et al. Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler Thromb Vasc Biol 1996, 16(4):576-584. 10.1161/01.ATV.16.4.576, 8624780.
42. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316(5830):1488-1491. 10.1126/science.1142447, 2711874, 17478681.
43. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316(5830):1491-1493. 10.1126/science.1142842, 17478679.
44. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357(5):443-453. 10.1056/NEJMoa072366, 2719290, 17634449.
45. Angelakopoulou A, Shah T, Sofat R, Shah S, Berry DJ, Cooper J, Palmen J, Tzoulaki I, Wong A, Jefferis BJ, et al. Comparative analysis of genome-wide-association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration. Eur Heart J 2011, 3:1-2.
46. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316(22):1371-1375. 10.1056/NEJM198705283162204, 3574413.
47. McPherson DD, Sirna SJ, Hiratzka LF, Thorpe L, Armstrong ML, Marcus ML, Kerber RE. Coronary arterial remodeling studied by high-frequency epicardial echocardiography: an early compensatory mechanism in patients with obstructive coronary atherosclerosis. J Am Coll Cardiol 1991, 17(1):79-86. 10.1016/0735-1097(91)90707-G, 1987244.
48. Stiel GM, Stiel LS, Schofer J, Donath K, Mathey DG. Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease. Circulation 1989, 80(6):1603-1609. 10.1161/01.CIR.80.6.1603, 2598424.
49. Hermiller JB, Tenaglia AN, Kisslo KB, Phillips HR, Bashore TM, Stack RS, Davidson CJ. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993, 71(8):665-668. 10.1016/0002-9149(93)91007-5, 8447262.
50. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000, 101(6):598-603. 10.1161/01.CIR.101.6.598, 10673250.
51. Okura H, Kobayashi Y, Sumitsuji S, Terashima M, Kataoka T, Masutani M, Ohyanagi M, Shimada K, Taguchi H, Yasuga Y, et al. Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome. Am J Cardiol 2009, 103(6):791-795. 10.1016/j.amjcard.2008.11.030, 19268733.
52. Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, Mayer B, Erdmann J, Klein G, Riegger G, Jacob HJ, et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 2005, 111(7):855-862. 10.1161/01.CIR.0000155611.41961.BB, 15710764.
53. Nishioka T, Nagai T, Luo H, Kitamura K, Hakamata N, Akanuma M, Katsushika S, Uehata A, Takase B, Isojima K, et al. Coronary remodeling of proximal and distal stenotic atherosclerotic plaques within the same artery by intravascular ultrasound study. Am J Cardiol 2001, 87(4):387-391. 10.1016/S0002-9149(00)01388-6, 11179519.
54. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A, Jones GT, Rinkel GJ, Blankensteijn JD, Ronkainen A, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008, 40(2):217-224. 10.1038/ng.72, 18176561.
55. Biros E, Cooper M, Palmer LJ, Walker PJ, Norman PE, Golledge J. Association of an allele on chromosome 9 and abdominal aortic aneurysm. Atherosclerosis 2010, 212(2):539-542. 10.1016/j.atherosclerosis.2010.06.015, 2952706, 20605023.
56. Thompson AR, Golledge J, Cooper JA, Hafez H, Norman PE, Humphries SE. Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion. Eur J Hum Genet 2009, 17(3):391-394. 10.1038/ejhg.2008.196, 2986176, 18854858.
57. Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, Simon M, Krex D, Arlier Z, Nayak N, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010, 42((5):420-425. 2861730, 20364137.
58. Nakaoka H, Takahashi T, Akiyama K, Cui T, Tajima A, Krischek B, Kasuya H, Hata A, Inoue I. Differential effects of chromosome 9p21 variation on subphenotypes of intracranial aneurysm: site distribution. Stroke 2010, 4(8):1593-1598.
59. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312(5770):117-121. 10.1126/science.1124287, 1482474, 16601194.
60. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, Frazer JR, Sun S, Baker AL, Newburger JW, et al. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 2011, 4(1):16-25. 10.1161/CIRCGENETICS.110.940858, 3073847, 21127203.
61. Pannu H, Fadulu VT, Chang J, Lafont A, Hasham SN, Sparks E, Giampietro PF, Zaleski C, Estrera AL, Safi HJ, et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005, 112(4):513-520. 10.1161/CIRCULATIONAHA.105.537340, 16027248.
62. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005, 37(3):275-281. 10.1038/ng1511, 15731757.
63. van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, Hoedemaekers YM, Willemsen R, Severijnen LA, Venselaar H, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 2011, 43(2):121-126. 10.1038/ng.744, 21217753.
64. Prakash SK, LeMaire SA, Guo DC, Russell L, Regalado ES, Golabbakhsh H, Johnson RJ, Safi HJ, Estrera AL, Coselli JS, et al. Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections. Am J Hum Genet 2010, 87(6):743-756. 10.1016/j.ajhg.2010.09.015, 2997376, 21092924.